(The author is a Reuters Breakingviews columnist. The opinions
expressed are their own.)
TORONTO, Jan 10 (Reuters Breakingviews) - Tilray TLRY.TO
is giving investors a double hit of good news. The Canadian pot
company said https://ir.tilray.com/news-releases/news-release-details/tilray-inc-reports-profitable-second-quarter-fiscal-year-2022
on Monday that it eked out a net profit in the quarter to Nov.
30 from a loss the year prior and that revenue rose about 20% to
$155 million in the period urn:newsml:reuters.com:*:nL4N2TQ28R, sending its shares up
18% by mid-morning. That’s thanks in part to diversification
into alcohol and wellness products. Its merger with Aphria
urn:newsml:reuters.com:*:nL1N2IW1CH, which closed in May last year, also appears to be
on track. The company expects to reach its original $80 million
annual cost-cutting target ahead of schedule and generate an
additional $20 million in synergies.
That’s not a bad position to be in for Tilray Brands, the
company's new name. Profitability has been elusive for many
producers in Canada, while once hyped-up valuations have fallen
across the board. Like others itching to access the more
lucrative U.S. market urn:newsml:reuters.com:*:nL1N2T6169, Tilray is hanging its hopes
on the hazy prospect of federal legalization. Yet the sector has
become increasingly competitive. It’s no wonder investors are
clinging onto any good news. (By Sharon Lam)
Follow @Breakingviews https://twitter.com/Breakingviews on
Twitter
Capital Calls - More concise insights on global finance:
SEC’s unicorn hunt is a luxury urn:newsml:reuters.com:*:nL4N2TQ316
UK cements business flakiness with builder U-turn
urn:newsml:reuters.com:*:nL4N2TQ2Y4
Atos’ latest profit warning keeps new CEO busy urn:newsml:reuters.com:*:nL4N2TQ28Z
Permira picks good time to flog some Dr. Martens
urn:newsml:reuters.com:*:nL4N2TM283
HSBC edges out of China sin bin with new deals urn:newsml:reuters.com:*:nL1N2TM02B
(Editing by Richard Beales and Amanda Gomez)
((SIGN UP FOR BREAKINGVIEWS EMAIL ALERTS: https://bit.ly/BVsubscribe))